***Meeting program subject to change.
Available Formats: = In Person
= On Demand
4:00–8:00 PM
Riverview Lounge
6:00–8:00 PM
Riverview Lounge
7:00–8:00 AM
Alberta/New Brunswick
Welcome and Keynote Address
8:00–9:00 AM
Alhambra
Uri Alon, Weizmann Institute of Science
Systems Medicine: Cell Therapies as Agents to Rewire the Physiological Circuits of Disease
New Cell Types for Therapy
9:00–11:15 AM
Alhambra
Nicholas Arpaia, Columbia University Irving Medical Center
Engineered Probiotic Bacteria for Cancer Immunotherapy
Yiyin Erin Chen, Broad Institute of MIT and Harvard
Skin Microbiota to Manipulate Immune Responses
Frederick Bennett, University of Pennsylvania
Microglia Replacement
Short Talk(s) Chosen from Abstracts
9:30–9:50 AM
Riverview Lounge
11:15–1:00 PM
Alberta/New Brunswick
1:00–10:00 PM
Alberta/New Brunswick
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Alhambra
Short Talks Chosen from Abstracts
4:30–5:00 PM
Riverview Lounge
Cell Therapies for Autoimmunity and Inflammation
5:00–7:00 PM
Alhambra
Georg A Schett, Uniklinikum Erlangen
Cell Therapies for Lupus
Ashley K. Koegel, Bristol Myers Squibb
Autoimmune Cell Therapies
Megan K. Levings, University of British Columbia
CAR Tregs
Short Talk(s) Chosen from Abstracts
7:00–8:00 PM
Alberta/New Brunswick
7:30–10:00 PM
Alberta/New Brunswick
7:00–8:00 AM
Alberta/New Brunswick
Foundational Synthetic Biology Tools for Cell Engineering
8:00–11:00 AM
Alhambra
Wendell A. Lim, University of California, San Francisco
Cells as Integrators of Complex Functions
Amanda Iniguez, Moonlight Bio
Cell Therapies using T Cell Tumor Drivers
Xiaojing Gao, Stanford University
Biomolecular Circuits as Medicine
Short Talk(s) Chosen from Abstracts
9:00–9:20 AM
Riverview Lounge
11:00–1:00 PM
Alberta/New Brunswick
1:00–10:00 PM
Alberta/New Brunswick
Career Roundtable (Joint)
1:45–2:45 PM
Alhambra
Panel Discussion: Regulatory Hurdles for Cell Therapies
3:00–4:30 PM
Alhambra
Vinay Prasad †, US Food and Drug Administration
4:30–5:00 PM
Riverview Lounge
Cancer Cell Therapies: Preclinical
5:00–7:00 PM
Alhambra
Emily Beura, Kelonia Therapeutics
in vivo Engineering using iGPS Technology
Robbie G. Majzner, Dana Farber Cancer Institute
Cancer Cell Therapy
Mark Yarmarkovich, New York University
Peptide Centric CARs
Short Talk(s) Chosen from Abstracts
7:00–8:00 PM
Alberta/New Brunswick
7:30–10:00 PM
Alberta/New Brunswick
7:00–8:00 AM
Alberta/New Brunswick
Cancer Cell Therapies: Clinical
8:00–11:00 AM
Alhambra
Claudia Rossig, University of Münster
GD2-Targeted CAR T Cell Therapies for Solid Cancers
Kristen Hege, Independent board member, Adaptimmune, Mersana, Kelonia, KSQ, EvolveImmune.
GART Lessons Learned Guiding Next Gen Cell Therapies
Marcela V. Maus, Harvard Medical School
Cell Therapies for Glioblastoma and Beyond
Andras Heczey, Baylor College of Medicine
GPC3-CAR T Cells for Patients with Solid Tumors
Short Talk(s) Chosen from Abstracts
9:00–9:20 AM
Riverview Lounge
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Alhambra
Short Talks Chosen from Abstracts
4:30–5:00 PM
Riverview Lounge
Cell Therapies for Regeneration
5:00–6:45 PM
Alhambra
Stefan Irion, BlueRock Therapeutics
Cell Therapy for Neurodegenerative Disease
Faranak Fattahi, University of California, San Francisco
Peripheral Nerve Regeneration
Jacob H. Hanna, Weizmann Institute of Science
Utilizing Synthetic Embryo Models for Enhanced Stem Cell Differentiation
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Alhambra
7:00–8:00 PM
Alberta/New Brunswick
